Delayed Intracranial Hemorrhage After Mild Traumatic Brain Injury in Patients on Oral Anticoagulants: Is the Juice Worth the Squeeze?

Total Page:16

File Type:pdf, Size:1020Kb

Delayed Intracranial Hemorrhage After Mild Traumatic Brain Injury in Patients on Oral Anticoagulants: Is the Juice Worth the Squeeze? European Review for Medical and Pharmacological Sciences 2021; 25: 3066-3073 Delayed intracranial hemorrhage after mild traumatic brain injury in patients on oral anticoagulants: is the juice worth the squeeze? M. COVINO1,2, A. MANNO1, G.M. DELLA PEPA3, A. PICCIONI1, G. TULLO1, M. PETRUCCI1, S. NAVARRA1, F. SARDEO1, E. TORELLI1, R. NICOLÒ1, B. SIMEONI1, L. CARBONE1, S. GAUDINO2,4, F. FRANCESCHI1,2 1Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy 2Università Cattolica del Sacro Cuore, Rome, Italy 3Institute of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy 4Department of Neuroradiology, Institute of Radiology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy Abstract. – OBJECTIVE: Mild Traumatic a routine control CT scan seems advisable only Brain Injury (MTBI) in anticoagulated patients is for patients presenting a clinical deterioration. a common challenge for Emergency Department Larger, prospective trials are required to clari- (ED) Physicians. Anticoagulation is considered fy the safety profile of DOACs vs. VKA in MTBI. a risk factor for developing delayed intracranial hemorrhage (ICH) after MTBI. The occurrence of Key Words: this event in patients on Vitamin K Antagonists Mild traumatic brain injury, Anticoagulation, Direct (VKA) or Direct Oral Anticoagulants (DOACs) re- oral anticoagulants, Intracranial hemorrhage. mains unclear. Primary endpoint: to analyze the role of anticoagulants as risk factors for devel- oping delayed ICH after MTBI and evaluate the Introduction indications to repeat a cranial computed tomog- raphy (CT) after a period of observation. Sec- Traumatic brain injury (TBI) represents one ondary endpoint: to assess the difference in the prevalence rate of delayed ICH in patients on of the most common causes of morbidity and VKA versus those on DOACs. mortality worldwide. In Europe, the incidence PATIENTS AND METHODS: We evaluated all rate is 235/100,000, with an average mortality consecutive patients admitted to our ED for MT- rate of 15/100,000 and an estimated annual cost BI, which had a control CT for late ICH after a of 33 billion Euros1. Approximately 80% of all negative CT at admission. We used a propen- TBI are mild (MTBI)2. The opportunity to sub- sity score match (PSM) on factors affecting the need for oral anticoagulation to adjust the com- mit patients with MTBI to computed tomography parison between anticoagulated vs. non-antico- (CT) at admission to the emergency department agulated patients for the baseline clinical char- (ED) is well established2,3. However, there is still acteristics. a lack of consensus on routine CT repeat after a RESULTS: Among 685 patients enrolled, 15 period of clinical observation3,4. MTBI common- (2.2%) developed ICH at control CT. After PSM, ly occurs in older patients, which have increased the incidence of ICH, although slightly high- fall risk, and commonly need anticoagulation for er, was not statistically different in anticoagu- 5 lated patients vs. non-anticoagulated (2.3% vs. several clinical conditions . Assumption of long- 0.6%, p=0.371). Among the 111 patients on VKA, term oral anticoagulants is traditionally consid- 5 (4.5%) had a late ICH, compared to 4 out of 99 ered an independent risk factor for developing (4.0%) on DOACs; the difference was not statis- both immediate than delayed intracranial hemor- tically significant (p=0.868). rhage (ICH) after MTBI6 but not all investigators CONCLUSIONS: The risk of developing de- agree7. Moreover, while for patients on vitamin layed ICH after MTBI in patients on anticoagu- K antagonist (VKA), available data are relatively lation therapy is low. After correction for base- 8,9 line covariates, the risk does not appear higher consistent , minor evidence exists for patients on compared to non-anticoagulated patients. Thus, Direct Oral Anticoagulants (DOAC)10-12. Howev- 3066 Corresponding Author: Marcello Covino, MD; e-mail: [email protected] Delayed intracranial hemorrhage and anticoagulation in MTB er, current studies suggest that the risk of adverse • Patients with a known history of inherited co- outcomes following a MTBI could be low for agulation disease; these patients13. • Patients that had a positive finding at first CT This study’s primary endpoint is to analyze the scan assessment. role of anticoagulants as risk factors for develop- ing delayed ICH after MTBI. The secondary end- For all patients included, we extracted the fol- point is to assess the difference in the prevalence lowing data by manually reviewing the clinical rate of delayed ICH in patients on VKA versus records: those on DOACs. • Demographics, including sex and age at the index admission; • Anticoagulant therapy at the time of injury, in- Patients and Methods cluding VKA DOACs or low-molecular-weight heparin (either therapeutic or prophylaxis dos- Study Design and Setting ing); The present paper reports the result of an ob- • Antiplatelet drug therapy, including aspirin or servational, cross-sectional study conducted in an clopidogrel; Emergency Department admitting about 77,000 • Presence of comorbidities, including history patients per year, in an urban teaching hospital. of neoplasia, neurodegenerative diseases, cere- The study was conducted over a three-year peri- brovascular diseases, thrombocytopenia, epi- od between January 1st, 2016 and December 31st, lepsy, and alcohol abuse; 2018. Our institution serves a metropolitan area, • Neurological and physical examination data and our hospital is a referral center for several at admission and during the ED observation peripheral Emergency Departments, and it is a period. major trauma center. CT Scan Evaluation Patients Selection and Data Extraction Decision-making to perform CCT was always We performed an automatized search of the taken by a board-certified emergency physician ED electronic clinical records based on admis- based on clinical evaluation and NICE guide- sion and discharge diagnosis. We included all lines4. Axial CT images were acquired at 2.5 mm consecutive records of patients admitted to our slices on a 64 slide CT scan [Revolution CT, GE ED for MTBI as chief complaint who, after a first Healthcare]. Cranial computed tomography scan negative CT scan at admission, repeated a CT interpretations were performed in all cases by ex- scan 24 hours later. MTBI was defined as TBI perienced neuro-radiologists. CT was considered with Glasgow Coma Score (GCS) ≥ 13, loss of positive if any kind of acute intracranial bleeding consciousness < 30 minutes, and post-traumatic was found (regardless of the amount), including amnesia < 24 hours [3]. subarachnoid hemorrhage, subdural hematoma, Our standard ED protocol indicates for all MT- epidural hematoma, intra-parenchymal hemor- BI patient a 6-hour observation. Patients receive a rhage, and cerebral contusion. Results of the CT head CT scan at admission, based on emergency scans were obtained from radiologists’ reports. physician evaluation. Patients who experience any clinical worsening during the observation Event Adjudication period [episode of epilepsy, vomit ≥ 2 episodes, We evaluated the number of patients that had a persistence of GCS < 15, prolonged amnesia, positive control CT scan, after an index negative persistent headache], are prescribed a prolonged CT assessment in our ED. observation and a 24-hour repeat CT scan. All patients on anticoagulant therapy (either VKA or Statistical Analysis DOAC) get a prolonged observation and a con- Continuous variables are reported as median trol CT scan at 24 hours from the index control. [interquartile range]. Categorical variables are Control CT scan could be anticipated based on reported as absolute numbers (%). Statistical uni- evolving clinical findings. variate comparison with respect of primary study We excluded from analysis: endpoint was assessed by Mann-Whitney U test • Trauma not classified as MTBI; for continuous variables, and Chi-square test • Patients <18 years of age; (with Yates correction or Fisher test if appropri- • Pregnant women; ate) for categorical variables. 3067 M. Covino, A. Manno, G.M. Della Pepa, A. Piccioni, G. Tullo, et al. Since this is a retrospective study, and criteria excluding criteria, we enrolled 685 patients in the for prescription of anticoagulation therapy in- study. The median age was 79 years [Interquartile clude several comorbidities and are often age-de- range 64.5-86]; 329 (48%) were males (Table I). pendent, we used a propensity score matching Overall, 210 patients (30.7%) were on anticoagu- (PSM) analysis to compare non-anticoagulated lant therapy. Among them, 111 (52.8%) were on vs. anticoagulated patients in order to adjust the VKA and 99 (47.2%) on DOACs. In the DOACs result of our study for these baseline factors. group 23 (11.0%) were on dabigatran, 37 (17.6%) PSM was generated using a logistic regression on apixaban, 31 (14.8%) on rivaroxaban and 9 model on the covariates considered potentially (4.3%) on edoxaban. influencing the decision to prescribe anticoagu- Control CT was positive for delayed ICH in 15 lation and adding any confounding factors iden- (2.2%) cases (Table I). tified as significantly associated to hemorrhage. Of the 15 patients with ICH after MTBI, one Variable considered for PSM were age, gender, refused admission to the ward (no anticoagulant ASA, clopidogrel, LMW heparin, alcohol abuse, therapy assumed), three were discharged from malignancy, and high energy trauma. Additional the ED after a 24-hour clinical control.
Recommended publications
  • Spinal Cord Injury and Traumatic Brain Injury Research Grant Program Report 2020
    This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Spinal Cord Injury and Traumatic Brain Injury Research Grant Program Report January 15, 2020 Author About the Minnesota Office of Higher Education Alaina DeSalvo The Minnesota Office of Higher Education is a Competitive Grants Administrator cabinet-level state agency providing students with Tel: 651-259-3988 financial aid programs and information to help [email protected] them gain access to postsecondary education. The agency also serves as the state’s clearinghouse for data, research and analysis on postsecondary enrollment, financial aid, finance and trends. The Minnesota State Grant Program is the largest financial aid program administered by the Office of Higher Education, awarding up to $207 million in need-based grants to Minnesota residents attending eligible colleges, universities and career schools in Minnesota. The agency oversees other state scholarship programs, tuition reciprocity programs, a student loan program, Minnesota’s 529 College Savings Plan, licensing and early college awareness programs for youth. Minnesota Office of Higher Education 1450 Energy Park Drive, Suite 350 Saint Paul, MN 55108-5227 Tel: 651.642.0567 or 800.657.3866 TTY Relay: 800.627.3529 Fax: 651.642.0675 Email: [email protected] Table of Contents Introduction 1 Spinal Cord Injury and Traumatic Brain Injury Advisory Council 1 FY 2020 Proposal Solicitation Schedule
    [Show full text]
  • Traumatic Brain Injury
    REPORT TO CONGRESS Traumatic Brain Injury In the United States: Epidemiology and Rehabilitation Submitted by the Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention The Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation is a publication of the Centers for Disease Control and Prevention (CDC), in collaboration with the National Institutes of Health (NIH). Centers for Disease Control and Prevention National Center for Injury Prevention and Control Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention Debra Houry, MD, MPH Director, National Center for Injury Prevention and Control Grant Baldwin, PhD, MPH Director, Division of Unintentional Injury Prevention The inclusion of individuals, programs, or organizations in this report does not constitute endorsement by the Federal government of the United States or the Department of Health and Human Services (DHHS). Suggested Citation: Centers for Disease Control and Prevention. (2015). Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention. Atlanta, GA. Executive Summary . 1 Introduction. 2 Classification . 2 Public Health Impact . 2 TBI Health Effects . 3 Effectiveness of TBI Outcome Measures . 3 Contents Factors Influencing Outcomes . 4 Effectiveness of TBI Rehabilitation . 4 Cognitive Rehabilitation . 5 Physical Rehabilitation . 5 Recommendations . 6 Conclusion . 9 Background . 11 Introduction . 12 Purpose . 12 Method . 13 Section I: Epidemiology and Consequences of TBI in the United States . 15 Definition of TBI . 15 Characteristics of TBI . 16 Injury Severity Classification of TBI . 17 Health and Other Effects of TBI .
    [Show full text]
  • Intracranial Hemorrhage As Initial Presentation of Cerebral Venous Sinus Thrombosis
    Case Report Journal of Heart and Stroke Published: 31 Dec, 2019 Intracranial Hemorrhage as Initial Presentation of Cerebral Venous Sinus Thrombosis Joseph Y Chu1* and Marc Ossip2 1Department of Medicine, University of Toronto, Canada 2Department of Diagnostic Imaging, William Osler Health System, Canada Abstract Intracranial Hemorrhage (ICH) as initial presentation is an uncommon complication of Cerebral Venous-Sinus Thrombosis (CVT). Clinical and neuro-imaging studies of 4 cases of ICH due cerebral venous-sinus thrombosis seen at the William Osler Health System in Toronto will be presented. Discussion of the immediate and long-term management of these interesting cases will be reviewed with emphasis on the appropriate neuro-imaging studies. Literature review of Direct Oral Anticoagulants (DOAC) in the long-term management of these challenging cases will be discussed. Introduction The following are four cases of Cerebral Venous-Sinus Thrombosis (CVT) who present initially as Intracranial Hemorrhage (ICH). Clinical details, including immediate and long term management and neuro-imaging studies are presented. Results Case 1 A 43 years old R-handed house wife, South-Asian decent, who was admitted to hospital on 06- 10-2014 with sudden headache and right hemiparesis. Her past health shows no prior hypertension or stroke. She is not on any hormone replacement therapy, non-smoker and non-drinker. Married with 1 daughter. Examination shows BP=122/80, P=70 regular, GCS=15, with right homonymous hemianopsia, right hemiparesis: arm=leg 1/5, extensor R. Plantar response. She was started on IV Heparin after her unenhanced CT showed acute left parietal intracerebral hemorrhage and her MRV showed extensive sagittal sinus thrombosis extending into the left transverse OPEN ACCESS sinus (Figures 1,2).
    [Show full text]
  • Early Management of Retained Hemothorax in Blunt Head and Chest Trauma
    World J Surg https://doi.org/10.1007/s00268-017-4420-x ORIGINAL SCIENTIFIC REPORT Early Management of Retained Hemothorax in Blunt Head and Chest Trauma 1,2 1,8 1,7 1 Fong-Dee Huang • Wen-Bin Yeh • Sheng-Shih Chen • Yuan-Yuarn Liu • 1 1,3,6 4,5 I-Yin Lu • Yi-Pin Chou • Tzu-Chin Wu Ó The Author(s) 2018. This article is an open access publication Abstract Background Major blunt chest injury usually leads to the development of retained hemothorax and pneumothorax, and needs further intervention. However, since blunt chest injury may be combined with blunt head injury that typically requires patient observation for 3–4 days, other critical surgical interventions may be delayed. The purpose of this study is to analyze the outcomes of head injury patients who received early, versus delayed thoracic surgeries. Materials and methods From May 2005 to February 2012, 61 patients with major blunt injuries to the chest and head were prospectively enrolled. These patients had an intracranial hemorrhage without indications of craniotomy. All the patients received video-assisted thoracoscopic surgery (VATS) due to retained hemothorax or pneumothorax. Patients were divided into two groups according to the time from trauma to operation, this being within 4 days for Group 1 and more than 4 days for Group 2. The clinical outcomes included hospital length of stay (LOS), intensive care unit (ICU) LOS, infection rates, and the time period of ventilator use and chest tube intubation. Result All demographics, including age, gender, and trauma severity between the two groups showed no statistical differences.
    [Show full text]
  • Symptomatic Intracranial Hemorrhage (Sich) and Activase® (Alteplase) Treatment: Data from Pivotal Clinical Trials and Real-World Analyses
    Symptomatic intracranial hemorrhage (sICH) and Activase® (alteplase) treatment: Data from pivotal clinical trials and real-world analyses Indication Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3 months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding (e.g., some neoplasms, arteriovenous malformations, or aneurysms); bleeding diathesis; and current severe uncontrolled hypertension. Please see select Important Safety Information throughout and the attached full Prescribing Information. Data from parts 1 and 2 of the pivotal NINDS trial NINDS was a 2-part randomized trial of Activase® (alteplase) vs placebo for the treatment of acute ischemic stroke. Part 1 (n=291) assessed changes in neurological deficits 24 hours after the onset of stroke. Part 2 (n=333) assessed if treatment with Activase resulted in clinical benefit at 3 months, defined as minimal or no disability using 4 stroke assessments.1 In part 1, median baseline NIHSS score was 14 (min: 1; max: 37) for Activase- and 14 (min: 1; max: 32) for placebo-treated patients. In part 2, median baseline NIHSS score was 14 (min: 2; max: 37) for Activase- and 15 (min: 2; max: 33) for placebo-treated patients.
    [Show full text]
  • NIH Public Access Author Manuscript J Neuropathol Exp Neurol
    NIH Public Access Author Manuscript J Neuropathol Exp Neurol. Author manuscript; available in PMC 2010 September 24. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Neuropathol Exp Neurol. 2009 July ; 68(7): 709±735. doi:10.1097/NEN.0b013e3181a9d503. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy following Repetitive Head Injury Ann C. McKee, MD1,2,3,4, Robert C. Cantu, MD3,5,6,7, Christopher J. Nowinski, AB3,5, E. Tessa Hedley-Whyte, MD8, Brandon E. Gavett, PhD1, Andrew E. Budson, MD1,4, Veronica E. Santini, MD1, Hyo-Soon Lee, MD1, Caroline A. Kubilus1,3, and Robert A. Stern, PhD1,3 1 Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 2 Department of Pathology, Boston University School of Medicine, Boston, Massachusetts 3 Center for the Study of Traumatic Encephalopathy, Boston University School of Medicine, Boston, Massachusetts 4 Geriatric Research Education Clinical Center, Bedford Veterans Administration Medical Center, Bedford, Massachusetts 5 Sports Legacy Institute, Waltham, MA 6 Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts 7 Department of Neurosurgery, Emerson Hospital, Concord, MA 8 CS Kubik Laboratory for Neuropathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Abstract Since the 1920s, it has been known that the repetitive brain trauma associated with boxing may produce a progressive neurological deterioration, originally termed “dementia pugilistica” and more recently, chronic traumatic encephalopathy (CTE). We review the 47 cases of neuropathologically verified CTE recorded in the literature and document the detailed findings of CTE in 3 professional athletes: one football player and 2 boxers.
    [Show full text]
  • Canadian Stroke Best Practice Recommendations
    CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACEREBRAL HEMORRHAGE Seventh Edition - New Module 2020 Ashkan Shoamanesh (Co-chair), M. Patrice Lindsay, Lana A Castellucci, Anne Cayley, Mark Crowther, Kerstin de Wit, Shane W English, Sharon Hoosein, Thien Huynh, Michael Kelly, Cian J O’Kelly, Jeanne Teitelbaum, Samuel Yip, Dar Dowlatshahi, Eric E Smith, Norine Foley, Aleksandra Pikula, Anita Mountain, Gord Gubitz and Laura C. Gioia(Co-chair), on behalf of the Canadian Stroke Best Practices Advisory Committee in collaboration with the Canadian Stroke Consortium and the Canadian Hemorrhagic Stroke Trials Initiative Network (CoHESIVE). © 2020 Heart & Stroke October 2020 Heart and Stroke Foundation Management of Spontaneous Intracerebral Hemorrhage Canadian Stroke Best Practice Recommendations Table of Contents CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACERBRAL HEMORRHAGE SEVENTH EDITION, 2020 Table of Contents Topic Page Part One: Canadian Stroke Best Practice Recommendations Introduction and Overview I. Introduction 3 II. Spontaneous Intracerebral Hemorrhage Module Overview 3 III. Spontaneous Intracerebral Hemorrhage Definitions 4 IV. Guideline Development Methodology 4 V. Acknowledgements, Funding, Citation 6 VI. Figure One: Intracerebral Hemorrhage Patient Flow Map 8 Part Two: Canadian Stroke Best Practice Recommendations Spontaneous Intracerebral Hemorrhage 1. Emergency Management of Intracerebral Hemorrhage 9 1.1 Initial Clinical Assessment of Intracerebral Hemorrhage 9 1.2 Blood Pressure Management 10 1.3 Management of Anticoagulation 11 1.4 Consultation with Neurosurgery 12 1.5 Neuroimaging 12 1.5.1 Recommended additional urgent neuroimaging to confirm ICH diagnosis 12 1.5.2 Recommended additional etiological neuroimaging 13 1.6 Surgical management of Intracerebral Hemorrhage 13 Box One: Symptoms of Intracerebral Hemorrhage: 15 Box Two: Modified Boston Criteria (Linn 2010) 16 2.
    [Show full text]
  • Traumatic Brain Injury(Tbi)
    TRAUMATIC BRAIN INJURY(TBI) B.K NANDA, LECTURER(PHYSIOTHERAPY) S. K. HALDAR, SR. OCCUPATIONAL THERAPIST CUM JR. LECTURER What is Traumatic Brain injury? Traumatic brain injury is defined as damage to the brain resulting from external mechanical force, such as rapid acceleration or deceleration impact, blast waves, or penetration by a projectile, leading to temporary or permanent impairment of brain function. Traumatic brain injury (TBI) has a dramatic impact on the health of the nation: it accounts for 15–20% of deaths in people aged 5–35 yr old, and is responsible for 1% of all adult deaths. TBI is a major cause of death and disability worldwide, especially in children and young adults. Males sustain traumatic brain injuries more frequently than do females. Approximately 1.4 million people in the UK suffer a head injury every year, resulting in nearly 150 000 hospital admissions per year. Of these, approximately 3500 patients require admission to ICU. The overall mortality in severe TBI, defined as a post-resuscitation Glasgow Coma Score (GCS) ≤8, is 23%. In addition to the high mortality, approximately 60% of survivors have significant ongoing deficits including cognitive competency, major activity, and leisure and recreation. This has a severe financial, emotional, and social impact on survivors left with lifelong disability and on their families. It is well established that the major determinant of outcome from TBI is the severity of the primary injury, which is irreversible. However, secondary injury, primarily cerebral ischaemia, occurring in the post-injury phase, may be due to intracranial hypertension, systemic hypotension, hypoxia, hyperpyrexia, hypocapnia and hypoglycaemia, all of which have been shown to independently worsen survival after TBI.
    [Show full text]
  • Mild Traumatic Brain Injury and Concussion: Information for Adults
    Mild Traumatic Brain Injury and Concussion: Information for Adults Discharge Instructions You were seen today for a mild traumatic brain injury (mild TBI) or concussion. Watch for Danger Signs Use this handout to help you watch In rare cases, a dangerous blood clot that for changes in how you are feeling crowds the brain against the skull can develop or acting and to help you feel better. after a TBI. The people checking on you should call 911 or take you to an emergency Be sure to let a family member or department right away if you have: friend know about your injury and the types of symptoms to look out • A headache that gets worse and does not for. They may notice symptoms go away before you do and can help you. • Significant nausea or repeated vomiting • Unusual behavior, increased confusion, Schedule a follow-up appointment restlessness, or agitation with your regular doctor. • Drowsiness or inability to wake up Due to your injury, you may need to take some • Slurred speech, weakness, numbness, or time off from things like work or school. If so, ask decreased coordination your doctor for written instructions about when • Convulsions or seizures (shaking or you can safely return to work, school, sports, twitching) or other activities such as driving a car, riding a • Loss of consciousness (passing out) bike, or operating heavy equipment. More information on mild TBI and concussion, as well as tips to help you feel better, can be found at www.cdc.gov/TraumaticBrainInjury. Learn About Your Injury Mild TBI and concussions are brain injuries.
    [Show full text]
  • Guidelines for BLS/ALS Medical Providers Current As of March 2019
    Tactical Emergency Casualty Care (TECC) Guidelines for BLS/ALS Medical Providers Current as of March 2019 DIRECT THREAT CARE (DTC) / HOT ZONE Guidelines: 1. Mitigate any immediate threat and move to a safer position (e.g. initiate fire attack, coordinated ventilation, move to safe haven, evacuate from an impending structural collapse, etc). Recognize that threats are dynamic and may be ongoing, requiring continuous threat assessments. 2. Direct the injured first responder to stay engaged in the operation if able and appropriate. 3. Move patient to a safer position: a. Instruct the alert, capable patient to move to a safer position and apply self-aid. b. If the patient is responsive but is injured to the point that he/she cannot move, a rescue plan should be devised. c. If a patient is unresponsive, weigh the risks and benefits of an immediate rescue attempt in terms of manpower and likelihood of success. Remote medical assessment techniques should be considered to identify patients who are dead or have non-survivable wounds. 4. Stop life threatening external hemorrhage if present and reasonable depending on the immediate threat, severity of the bleeding and the evacuation distance to safety. Consider moving to safety prior to application of the tourniquet if the situation warrants. a. Apply direct pressure to wound, or direct capable patient to apply direct pressure to own wound and/or own effective tourniquet. b. Tourniquet application: i. Apply the tourniquet as high on the limb as possible, including over the clothing if present. ii. Tighten until cessation of bleeding and move to safety.
    [Show full text]
  • Read Onlinepdf 18.98 MB
    ResidentOfficial Publication of the Emergency Medicine Residents’ Association December 2018/January 2019 VOL 45 / ISSUE 6 Exertional Rhabdomyolysis EmBassador Travel Team Seeking the Best and Brightest EM Physicians Enjoy the flexibility to live where you want and practice where you are needed. EmBassador TRAVEL TEAM PHYSICIANS RECEIVE: Paid travel and Practice variety accommodations Concierge support Travel convenience package Regional engagements, Paid medical staff dues, equitable scheduling and licenses, certifications and no mandatory long-term applications employment commitment Exceptional Fast track to future compensation package leadership opportunities For More Information: Mansoor Khan, MD National Director, EmBassador Program 917.656.6958 | [email protected] ENVISION PHYSICIAN SERVICES OFFERS ... programs that align physicians to become leaders MANSOOR KHAN, MD, MHA, FAAEM EMERGENCY MEDICINE Why EM Residents choose Envision Physician Services ■ Professional Development and Career Advancement ■ Employment Flexibility: Full-Time, Part-Time, moonlighting and travel team. Employed and Independent Contractor options ■ Practice Variety: Coast-to-coast opportunities at well-recognized hospitals and health systems ■ Unparalleled practice support ■ Earn While You Learn Program: Provides senior residents with $2,500/month while you complete your residency For more information, contact: 877.226.6059 [email protected] TABLE OF CONTENTS EDITORIAL STAFF Categories EDITOR-IN-CHIEF Tommy Eales, DO Indiana University COVER STORY DEPUTY
    [Show full text]
  • CDC Concussion Definition and Pathophysiology
    Concussion Definition and Pathophysiology The Evolving Definition of Concussion CDC Physicians Toolkit; Collins, Gioia et al 2006 Regarding Cerebral Concussion…… A concussion (or mild traumatic brain injury) is a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces secondary to direct or indirect forces to the head. Disturbance of brain function is related to neurometabolic dysfunction, rather than structural brain injury, and is typically associated with normal structural imaging findings (CT Scan, MRI). Concussion may or may not involve a loss of consciousness. Concussion results in a constellation of physical, cognitive, emotional, and sleep‐related symptoms. Recovery is a sequential process and symptoms may last from several minutes to days, weeks, months, or even longer in some cases.” . Following a concussion, there are metabolic chemical changes that take place in the brain. Brain injury can occur even if there is NO loss of consciousness. More than 90% of concussions DO NOT involve loss of consciousness. Memories of events BEFORE and AFTER the concussion are MORE accurate assessments of SEVERITY than loss of consciousness. Pathophysiology of Concussions – Dr. Micky Collins, Director UPMC Sports Medicine Concussion Program Neurometabolic Cascade of Concussion During activities a concussion can occur with any type of external force to the head. These events can cause the brain to accelerate and decelerate with translational, rotational and/or angular forces. Brain injuries can result on the side of the force, cu, or the opposite side of the force, contra cu. So what exactly do these forces do to the brain? Researchers believe it leads to a wave of energy that passes through the brain tissue triggering neuronal dysfunction.
    [Show full text]